Following the maxim of \u201cSmart people make smart investment decisions\u201d, the experts at Swissquote scrutinise the trading activities of members of the US Congress to form the US Congressional Trader Index. Developed specifically for this purpose, the algorithm analyses equities that are mentioned in documents which disclose trading activities, such as the Periodic Transaction Report (PTR). Swissquote\u2019s index is intended to create the same starting conditions for all investors so that they can potentially profit from the same insights that underpin the most successful portfolios in Washington.<\/p>\n\n
The Swissquote US Congressional Trader Index currently contains a total of 37 stocks, ranging from AMD through Eli Lilly to Wells Fargo. The absolute heavyweight in the strategy barometer is chip giant Nvidia, which accounts for more than six per cent. As the industry leader in the field of artificial intelligence (AI), the semiconductor manufacturer is the subject of particular focus at present. Just a few days after being sworn in as US president, Donald Trump announced plans to spend USDbn 500 on the creation of new data centres for AI in order to establish the USA as a pioneer in the sector. These efforts would also benefit other chip manufacturers such as AMD and Broadcom, who likewise boarded the AI train a long time ago. It is not surprising, then, that these two stocks are also members of the Swissquote US Congressional Trader Index.<\/p>\n\n\n\n
US congressional representatives are also investing outside the technology sector, though. Eli Lilly, for instance, is another of the top five on the Swissquote US Congressional Trader Index. The healthcare group has caught the spirit of the age with its \u201cMounjaro\u201d slimming drug and is on course for rapid growth. It saw sales increase by around a third last year and was even able to more than double its profits. For this year, too, the management board is forecasting a significant rise in profits as a result of the expansion of its popular diabetes and weight-loss products into new markets. \u201cWe are starting 2025 with strong tailwinds,\u201d explains CEO David Ricks. Other members of the strategy index include banks such as Goldman Sachs. The new US government is expected to deliver far-reaching deregulation initiatives from which financial institutions could benefit. Business at Goldman Sachs is already booming even without laxer rules, however: thanks to strong results in investment banking and flourishing trading business, profits more than doubled in the fourth quarter of 2024.<\/p>\n\n\n\n
Whether the top politicians in the USA are actively exploiting their wide-ranging knowledge or it is subtly influencing their decisions, the performance of their portfolios is certainly impressive. This alone is a good reason to follow their example. The Actively Managed Certificate (AMC) issued last year offers access to the broadly diversified and high-performance Swissquote US Congressional Trader Index. This actively managed tracker enables investors to participate 1:1 \u2013 minus a fee of 0.6 per cent p.a. and 0.1 per cent per transaction \u2013 in Swissquote's high-potential barometer. In return, the dividends paid flow into the calculation on a net basis. The product has no term limit and can be traded daily on the market.<\/p>\n\n\n\n
We look forward to answering all of your questions about our products and how they are traded. Please don't hesitate to get in touch! Phone: 058 800 11 11<\/a>, email info@leonteq.com<\/a> or contact us here<\/a>.\n<\/p>\n <\/div>","url":"swissquote-us-congressional-trader-index","investmentThemeVerticalImageUrl":"https://structuredproducts-ch-pub-uat.leonteq.com/product-news/sidenav-banner/us+politicians_leonteq-structured-products_sidenav+banner.jpg","thumbnailUrl":"https://structuredproducts-ch-pub-uat.leonteq.com/product-news/thumbnail/us+politicians_leonteq-structured-products_thumbnail.jpg"}